Division of Urology, Department of Regenerative and Transplant Medicine, Niigata Graduate School of Medical and Dental Sciences, Niigata, Japan.
Glycobiology. 2010 Oct;20(10):1251-8. doi: 10.1093/glycob/cwq086. Epub 2010 Jun 10.
The phenomenon of accommodation in recipients of blood group ABO incompatible kidney transplantation (iKTx), in which grafts survive despite the presence of blood group A or B antigen in the graft and the presence of corresponding antibodies in the recipient's blood, is not uncommon. alpha1,3-N-Acetylgalactosaminyltransferase and alpha1,3galactosyltransferase associated with the synthesis of blood group A and B antigen (A and B enzymes), respectively, were measured by a highly specific enzyme-linked immunosorbent assay in the sera and transplanted tissues of patients who underwent an ABO iKTx. Allogeneic A and B enzymes were present in the sera and tissues as well as A and B antigens in the tissues for a long period, which hitherto have never been seen in recipients prior to an iKTx. However, activities of these enzymes in the sera after an iKTx decreased in patients who experienced a serious acute antibody-mediated rejection and disappeared in patients who had an unrepairable rejection, leading to graft loss without establishment of accommodation. Our observations on the presence of allogeneic A and B enzymes in the recipients' sera should have implications in decision making for a successful iKTx.
受者在接受 ABO 血型不相容肾移植(iKTx)时会出现一种现象,即尽管移植物中存在血型 A 或 B 抗原,受者血液中存在相应的抗体,但移植物仍能存活。α1,3-N-乙酰半乳糖胺基转移酶和α1,3 半乳糖基转移酶分别与血型 A 和 B 抗原的合成有关(A 和 B 酶),我们通过高度特异性的酶联免疫吸附试验在接受 ABO iKTx 的患者的血清和移植组织中测量了这些酶。同种异体 A 和 B 酶以及组织中的 A 和 B 抗原在血清和组织中存在很长时间,这是在 iKTx 之前从未在受者中观察到的。然而,在经历严重急性抗体介导排斥反应的患者中,iKTx 后血清中这些酶的活性会降低,在无法修复排斥反应的患者中会消失,导致移植物丢失而无法建立适应。我们在受者血清中观察到同种异体 A 和 B 酶的存在,这可能对成功进行 iKTx 的决策具有重要意义。